Capstone Investment Advisors
CBPO

Capstone Investment Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Capstone Investment Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-342,100
Closed -$40.5M – 2071
2021
Q1 		$40.5M Sell
342,100
-424,188
-55% -$50.2M 0.12% 164
2020
Q4 		$90.5M Buy
766,288
+266,072
+53% +$30.9M 0.3% 54
2020
Q3 		$55.6M Buy
+500,216
New +$53.7M 0.28% 64
2017
Q2 		– Sell
-11,630
Closed -$1.16M – 1081
2017
Q1 		$1.16M Buy
11,630
+6,604
+131% +$706K 0.03% 388
2016
Q4 		$540K Buy
+5,026
New +$588K 0.02% 567
2016
Q3 		– Sell
-2,100
Closed -$223K – 997
2016
Q2 		$223K Buy
+2,100
New +$244K ﹤0.01% 612

Capstone Investment Advisors's CBPO Position: Q2 2021 in Review

Capstone Investment Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 342,100 shares — an estimated $40.5M sold.

Capstone Investment Advisors first reported a position in CBPO in Q2 2016 and held it in 6 quarters. The position peaked at $90.5M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Capstone Investment Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • Capstone Investment Advisors sold 342,100 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $40.5M.
  • Capstone Investment Advisors first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and held it in 6 quarters.
  • Capstone Investment Advisors's China Biologic Products Holdings, Inc. position peaked at $90.5M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Capstone Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.